Events

Below is a list of events where CELT researchers and staff are presenting CELT research, or events that CELT is endorsing.

A grand building at Queens University Belfast is above the text

British Society for Nanomedicine 2025 Annual Meeting

2-3 September 2025, Queens University Belfast Ireland

With four incredible keynote speakers, this two day event includes presentations (with an emphasis on early career researchers, industry and academic taskforce meetings, workshops, and discussion groups.

CELT's Dr Eduardo Gallardo Toledo is presenting 'Assessment of creatine kinase in rat plasma as indicator of tissue damage after intramuscular administration of approved long-acting injectable medicines'.

Find out more including how to register and submit an abstract via the BSNM Annual Meeting event page.

A flyer stating

26th International workshop on clinical pharmacology of HIV, hepatitis and other antiviral drugs 2025

3-4 September 2025, Amsterdam The Netherlands

CELT are an official endorser to the 26th Antiviral Workshop 2025, set to take place on 3-4 September in Amsterdam, the Netherlands.

This prestigious workshop brings together leading experts, researchers, and professionals from the field of clinical pharmacology to exchange knowledge, share insights, and discuss the latest therapeutic advancements for HIV, hepatitis, and other antiviral drugs. There are three CELT related presentations this year:

CELT's Co-Director Professor Andrew Owen is presenting an oral presentation titled 'Can low-cost oral alternatives be used in place of oral lenacapavir when initiating long-acting lenacapavir PrEP in low and middle income countries?'
Leader of the Perinatal Pharmacology Group, Dr Adeniyi Olagunju is presenting 'New models for drug exposure and safety during pregnancy'
Helen Reynolds, the clinical trials Programme Manager within the University of Liverpool's Centre for Experimental Therapeutics (TherEx) is presenting LONGEVITY project work, funded by global health agency Unitaid, titled 'Pharmacokinetics of nitazoxanide in plasma separation cards from patients with SARS‐CoV‐2: AGILE CST-3a/b'.

Find out more information, including how to register and submit an abstract on the Antiviral Workshop 2025 event page.

A green background says

Royce National Conference

3-4 September 2025, Manchester UK

Explore the transformative impact of material technologies on healthcare innovation.

The afternoon theme for Day 2 of the conference is 'From Materials to Medicine' and CELT's Dr James Hobson will be delivering a talk titled 'Development of long-acting therapeutics: Challenges and opportunities'.

For more information and to register, visit the Royce National Conference page.

IMPAACT Network Annual Meeting

4-11 September 2025, Online

This virtual event will bring together IMPAACT Network leadership, investigators, research site staff, community advocates, and network affiliates to discuss the network's scientific agenda and explore innovative approaches to future research.

Dr Adeniyi Olagunju who leads CELT's perinatal pharmacology work is presenting 'Long-acting therapeutics for maternal and paediatric health: summary of 1st July 2025 workshop the community of practice'.

Find out more, including how to register on the IMPAACT Network Annual Meeting page.

a shot of Cardiff from above, the text reads

16th PharmSci International Conference

8-9 September 2025, Cardiff UK

PharmSci 2025 aims to bring together industry experts, academics and thought leaders to exchange their knowledge and expertise. The speakers are selected so attendees receive the most valuable and relevant information.

CELT has two presentations at this year's conference:

CELT's Dr James Hobson from our Materials Chemistry group is presenting 'Development of long-acting therapeutics: Challenges and opportunities'.
Our Immunocompatibility group will be presenting 'Current landscape on the complexities associated with the delivery of long-acting drug formulations and long-acting injectables, which may impact biopharmaceutics'

As well as informative speaker sessions, PharmSci 2025 will provide networking opportunities with like-minded professionals.

For more information, including how to register, head to the conference event page.

Pharmacogenomics Global Research Network 2025 Scientific meeting in collaboration with ClinPGx

10-12 September 2025, Missoula USA

CELT's Dr Adeniyi Olagunju is presenting a talk titled 'Drug Exposure During Pregnancy and Lactation: Pharmacogenetic Considerations'.

Find the full programme and how to register on the PGRN 2025 meeting page.

CELT's Community of Practice for long-acting therapeutics for maternal and paediatric health

11 September 2025, online webinar

Community of Practice context

Significant gaps currently exist in the development of new medicines for women of child-bearing age and children, compared with the general adult population. This gap could expand further with new treatment modalities like long-acting therapeutics. Additionally, the extent of breastfed infant exposure through breast milk is largely unknown.

The overarching aim of this community of practice (funded by global health agency Unitaid) is to catalyse the development and availability of long-acting therapeutics of value for maternal and paediatric health globally, including in low- and middle- income countries.

This will be achieved through the following specific objectives:

Engaging relevant stakeholders in academia, clinical practice, pharmaceutical industry, regulators, women and patient groups
Synthesise evidence-based perspectives on best practices for long-acting therapeutics
Disseminate outputs from the community of practice for uptake by the wider community.

There are 9 meetings for the community of practice in 2025 (2 full community of practice meetings online (one has already occurred), 1 in person workshop and 6 shorter webinars (one has already occurred)). The next online session will be held on Thursday 11 September, 2025.

To join the Community of Practice and attend this meeting, please fill in this Expression of Interest form to receive an invite link.

We will use this Events page to keep you updated on the remaining events, so please check back. Members are welcome to join the community of practice at any point.

An image of Cape Town coast line with text to the left saying:

INHSU 2025: International Conference on Health and Hepatatis in Substance Users

14-17 October 2025, CapeTown South Africa

This year's conference around health and hepatitis in substance users that meaningfully involves people who use drugs is back in its home city for the first time in five years. Dr Marcia Vermeulen from the University of Cape Town will be presenting a talk on some exciting community engagement research for the LONGEVITY project.

For more information including booking, please head to the INHSU 2025 conference page.
(Early bird tickets available until 27 July)

AAPS 2025 PHarmSCi 360

9-12 November 2025, San Antonio USA

This four day conference is organised around six core areas; Discovery and basic research; Preclinical, clinical and translational sciences; Bioanalytics; Manufacturing and analytical characterization; Formulation and delivery; Professional advancement track.

Five members of CELT will be presenting at the conference.

Find out more, including how to register, on the PHarmSCi 360 event page.

Previous events

LEAP | New Approaches to Bioequivalence Assessment and Generic Approvals for Long Acting/Extended Release Antiretroviral Formulations

Find all the recordings from the workshop talks here.

LEAP | Long-acting Tuberculosis Drug Development Workshop 2024 - 15 April 2024

Watch CELT co-Director Prof. Andrew Owen's presentation here.

Find all the recordings from the workshop here.

19th Residential Course on Clinical Pharmacology and Antiretrovirals - 17-19 January 2024

Download the presentation decks here